Manufacturer of Controlled Substances Notice of Registration, 77189 [E5-8082]
Download as PDF
<![CDATA[
77189
Federal Register / Vol. 70, No. 249 / Thursday, December 29, 2005 / Notices
following Department of Justice Web
site: https://www.usdoj.gov/enrd/
open.html. A copy of the Consent
Decree may also be obtained by mail
from the Consent Decree Library, P.O.
Box 7611, U.S. Department of Justice,
Washington, DC 20044–7611, or by
faxing or e-mailing a request a Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax no. (202) 514–0097, phone
confirmation number (202) 513–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of $6.25 (25 cents per
page reproduction cost), payable to the
U.S. Treasury.
Ronald Gluck,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 05–24617 Filed 12–28–05; 8:45 am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
wwhite on PROD1PC65 with NOTICES
Notice of Proposed Agreement
Resolving Dispute Under Consent
Decree in United States v. Detroit
Diesel Corporation
Notice is hereby given of a proposed
Agreement Resolving Dispute Under
Consent Decree (‘‘Agreement’’) in the
case of United States v. Detroit Diesel
Corporation, Civil Action No. 98–02548,
in the United States District Court for
the District of Columbia.
The Agreement resolves two matters
involving DDC’s alleged failure to
comply with a 1999 Consent Decree
settling claims under Title II of the
Clean Air Act, 42 U.S.C. 7521 et seq.
(the ‘‘Act’’), regarding the alleged use of
illegal emission-control ‘‘defeat
devices’’ on DDC’s 1998 and prior
heavy-duty diesel engines (‘‘HDDEs’’).
The first matter concerns DDC’s use of
a computer-based auxiliary emission
control device (‘‘AECD’’) to control
‘‘white smoke,’’ i.e., visible exhaust
caused by incomplete combustion of
diesel fuel, on 35,667 model year 2000
Series 50 urban bus engines and model
year 2001 Series 60 HDDEs. The white
smoke AECD, which required EPA
approval, was not accurately described
in DDC’s applications to EPA for
regulatory ‘‘certificates of conformity’’
permitting the sale of the engines in the
United States. The second matter
concerns 2,096 model year 2003 and
2004 Series 50 urban bus engines that,
under specific engine operating
conditions, may emit particulate matter
(‘‘PM’’) at levels higher than the ‘‘not-toexceed’’ or ‘‘NTE’’ limit for PM imposed
by the Consent Decree.
VerDate Aug<31>2005
18:56 Dec 28, 2005
Jkt 208001
These violations are addressed
through DDC’s payment of stipulated
penalties in the amount of $535,000,
provisions for the completion of
previously initiated recalls to fix the
white smoke AECD and the NTE
exceedance engines until at least 24,967
of the former and all of the latter have
been repaired, and the mandatory
continuation of a program to obtain NOX
emission reductions through
modifications to the engine control
software (known as ‘‘early Low NOX
Rebuild’’ from older, higher emitting
engines manufactured by DDC and still
in use in trucks. DDC is required to
achieve at least 8,000 tons of NOX
emission reductions through early Low
NOX Rebuilds, and is also required to
continue this program beyond the 8,000ton requirement for so long as engines
for which its Low NOX Rebuild software
is available remain in service.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the Agreement. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Divisions, P.O. Box
7611, U.S. Department of Justice,
Washington, DC 20044–7611, and
should refer to United States v. Detroit
Diesel Corporation, D.J. Ref. 90–5–2–1–
2253.
During the public comment period,
the Agreement may be examined on the
following Department of Justice Web
site, https://www.usdoj.gov/enrd/
open.html.
A copy of the Agreement may also be
obtained by mail from the Consent
Decree Library, P.O. Box 7611, U.S.
Department of Justice, Washington, DC,
20044–7611 or by faxing or e-mailing a
request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation
number (202) 514–1547. In requesting a
copy of the Decree from the Consent
Decree Library, please enclose a check
in the amount of $4.25 (25 cents per
page reproduction cost for 210 pages)
payable to the U.S. Treasury.
Karen Dworkin,
Assistant Chief, Environmental Enforcement
Section.
[FR Doc. 05–24616 Filed 12–28–05; 8:45 am]
BILLING CODE 4410–15–M
PO 00000
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated June 8, 2005, and
published in the Federal Register on
June 15, 2005, (70 FR 34796),
Boehringer Ingelheim Chemical Inc.,
2820 N. Normandy Drive, Petersburg,
Virginia 23805, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules II:
Drug
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Methadone (9250) ........................
Methadone Intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Fentanyl (9801) ............................
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances for
formulation into finished
pharmaceuticals. Subsequent to the
Notice of Application, being published
in the Federal Register on June 15,
2005, Boehringer Ingelheim Chemical
Inc., requested the surrender of drug
code Levo-alphacetylmethadol (9648)
from their registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Boehringer Ingelheim Chemical Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Boehringer Ingelheim
Chemical Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration.
[FR Doc. E5–8082 Filed 12–28–05; 8:45 am]
BILLING CODE 4410–09–P
Frm 00072
Schedule
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 70, Number 249 (Thursday, December 29, 2005)]
[Notices]
[Page 77189]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-8082]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated June 8, 2005, and published in the Federal Register
on June 15, 2005, (70 FR 34796), Boehringer Ingelheim Chemical Inc.,
2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the basic classes of controlled substances
listed in Schedules II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for formulation into finished pharmaceuticals. Subsequent to the Notice
of Application, being published in the Federal Register on June 15,
2005, Boehringer Ingelheim Chemical Inc., requested the surrender of
drug code Levo-alphacetylmethadol (9648) from their registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Boehringer Ingelheim Chemical Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated Boehringer Ingelheim Chemical Inc.,
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. E5-8082 Filed 12-28-05; 8:45 am]
BILLING CODE 4410-09-P
